In this study, we aim to elucidate the relationship between CCND1, CDK4, p21, and NSCLC, with a specific focus on the mechanistic role of p21 in inhibiting CCND1-CDK4 complex activity. The gene discussed is CDKN1A; the disease is non-small cell lung carcinoma.